title: Disulfide locked variants of factor VIIa with a restricted beta-strand conformation have enhanced enzymatic activity.
abstract: Proteolytic processing of zymogen Factor VII to Factor VIIa (FVIIa) is necessary but not sufficient for maximal proteolytic activity, which requires an additional allosteric influence induced upon binding to its cofactor tissue factor (TF). A key conformational change affecting the zymogenicity of FVIIa involves a unique three-residue shift in the position of beta-strand B2 in their zymogen and protease forms. By selectively introducing new disulfide bonds, we locked the conformation of these strands into an active TF*FVIIa-like state. FVIIa mutants designated 136:160, 137:159, 138:160, and 139:157, reflecting the position of the new disulfide bond (chymotypsinogen numbering), were expressed and purified by TF affinity chromatography. Mass spectrometric analysis of tryptic peptides from the FVIIa mutants confirmed the new disulfide bond formation. Kinetic analysis of amidolytic activity revealed that all FVIIa variants alone had increased specific activity compared to wild type, the largest being for variants 136:160 and 138:160 with substrate S-2765, having 670- and 330-fold increases, respectively. Notably, FVIIa disulfide-locked variants no longer required TF as a cofactor for maximal activity in amidolytic assays. In the presence of soluble TF, activity was enhanced 20- and 12-fold for variants 136:160 and 138:160, respectively, compared to wild type. With relipidated TF, mutants 136:160 and 137:159 also had an approximate threefold increase in their V(max)/K(m) values for FX activation but no significant improvement in TF-dependent clotting assays. Thus, while large rate enhancements were obtained for amidolytic substrates binding at the active site, macro-molecular substrates that bind to FVIIa exosites entail more complex catalytic requirements.
authors.affiliation: Department of Protein Engineering, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA.
authors.forename: Henry R
authors.initials: HR
authors.lastname: Maun
authors.forename: Charles
authors.initials: C
authors.lastname: Eigenbrot
authors.forename: Helga
authors.initials: H
authors.lastname: Raab
authors.forename: David
authors.initials: D
authors.lastname: Arnott
authors.forename: Lilian
authors.initials: L
authors.lastname: Phu
authors.forename: Sherron
authors.initials: S
authors.lastname: Bullens
authors.forename: Robert A
authors.initials: RA
authors.lastname: Lazarus
mesh_terms: D000818:Animals; D016466:CHO Cells; D002846:Chromatography, Affinity; D006224:Cricetinae; D004220:Disulfides / Q000737:chemistry / Q000378:metabolism*; D015942:Factor VIIa / Q000737:chemistry / Q000378:metabolism*; D007700:Kinetics; D016296:Mutagenesis; D010957:Plasmids; D011487:Protein Conformation; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
chemical_list: D004220:Disulfides; D015942:Factor VIIa